Ge Long Hui·2025-09-18 08:37Group 1 - Tesla's stock rose approximately 2% in pre-market trading following the news of a partnership with PharmAGRl [1] - PharmAGRl has signed a letter of intent to deploy up to 10,000 Optimus 3+ humanoid robots in its agricultural operations, active pharmaceutical ingredient synthesis, and prescription drug production [1] - The robots are designed to comply with all regulations set by the DEA and FDA, capable of conducting independent audits and generating global inventory reports [1] Group 2 - Tesla's closing price was $425.860, with a pre-market price of $433.000, reflecting a 1.68% increase [1] - The stock's trading volume was 106 million, with a total market capitalization of $1.42 trillion [1] - The stock has a TTM price-to-earnings ratio of 253.49 and a price-to-book ratio of 18.315 [1]